1411 North Beckley Avenue, Suite 268
Dallas, Texas 75203
Recent statistics published by the American Liver Foundation state that currently, liver-related diseases affect more than 30 million Americans. That’s a lot of sick livers!
The Liver Institute at Methodist Dallas is a comprehensive, multidisciplinary disease management center specializing in diseases of the liver, bile ducts and pancreas. Located adjacent to Methodist Dallas Medical Center, The Liver Institute brings together a team of leading clinicians and researchers within the field of hepatology, gastroenterology, hepatobiliary-pancreatic surgery and organ transplantation. “We are a multi-specialty practice offering a broad scope of care to patients with any type and severity of liver disease,” said Hector E. Nazario, MD, transplant hepatologist and gastroenterologist. “Patients referred to our Institute receive personalized attention that is tailored to address their particular liver condition. Our patients also receive unobstructed access to all the different skilled specialists and services that recognize us as a premier hepatobiliary-pancreatic and transplant program.”
Meet the Specialists
Working collectively, the physicians and surgeons on staff at The Liver Institute offer complete patient care by providing both standard as well as innovative medical and surgical therapies encompassing all aspects of hepatobiliary and pancreatic diseases.
Maisha N. Barnes, MD
Transplant Hepatologist and Gastroenterologist
Fellowship trained and board certified in Transplant Hepatology, Gastroenterology and Internal Medicine, Dr. Barnes loves helping patients live healthier lives and is active in medical research in her field.
Edward Dominguez, MD
Medical Director, Organ Transplant and Infectious Disease
Dr. Dominguez was recognized in Best Doctors in America and specializes in general and transplant-related infectious diseases. With fellowship training and board certification in infectious disease, Dr. Dominguez is an expert in his field with special interest in immunocompromised host and outpatient anti-infective therapy.
Adil Habib, MD
Transplant Hepatologist and Gastroenterologist
Dr. Habib specializes in the management of viral hepatitis, complications of portal hypertension and cirrhosis, hepatocellular carcinoma, adult liver transplantation, medical complications after liver transplantation, and other gastrointestinal disorders. He is board certified in Transplant Hepatology and Gastroenterology.
Parvez Mantry, MD
Medical Director, Liver Institute Research; Medical Director, Hepatobiliary Tumor Program
With special interest in liver research, liver cancer and post-transplant hepatitis, Dr. Mantry’s experience in the area of liver transplantation at a high-volume transplant center is well-recognized. He is board certified in Transplant Hepatology, Gastroenterology and Internal Medicine.
Hector E. Nazario, MD
Chief of Division of Hepatology, Methodist Hospital-Dallas
Dr. Nazario specializes in the management of viral hepatitis, cholestatic and autoimmune liver diseases; complications of portal hypertension; cirrhosis; hepatocellular carcinoma; adult liver transplantation; medical complications after liver transplantation; and other gastrointestinal disorders. He is board certified in Transplant Hepatology, Gastroenterology and Internal Medicine.
Jeffrey Weinstein, MD
Medical Director of Liver Transplantation and Hepatobiliary Services
Dr. Weinstein specializes in the care of patients with acute and chronic liver disorders, cirrhosis, adult liver transplantation, and other gastrointestinal diseases. He is a founding physician of the practice and is board certified in Transplant Hepatology, Gastroenterology and Internal Medicine.
Stephen S. Cheng, MD, FACS
Medical Director, Transplant Informatics; Surgical Director, Liver Transplant and Hepatobiliary Services
Dr. Cheng has special interest and expertise in surgical management of benign and malignant hepatobiliary-pancreatic tumors, the management of cirrhosis and portal hypertension as well as in robotic-assisted (da Vinci®) surgeries and liver transplantation. He is certified by the American Board of Surgery and a member of the American Society of Transplant Surgeons.
Richard Dickerman, MD, FACS
Surgical Director, Kidney and Pancreas Transplant; General and Vascular Surgery
Dr. Dickerman is a clinical associate professor of surgery with the University of Texas Southwestern Medical School and is board certified by the American Board of Surgery. He is recognized as one of the leading vascular and kidney/pancreas transplant surgeons in Texas. Dr. Dickerman was instrumental in the development of the kidney and pancreas transplant program that has performed more than 2,500 transplants since 1981.
Carlos Fasola, MD
Dr. Fasola is an accomplished surgeon in adult kidney, pancreas, and liver transplantation with extensive training in living donor kidney transplantation. In addition to transplantation, he has keen interests in dialysis access and transplant outcome analysis. Dr. Fasola is certified by the American Board of Surgery.
Alejandro Mejia, MD, FACS
Executive Medical Director, Organ Transplantation
Dr. Mejia is certified by the American Board of Surgery and is a member of the American Society of Transplant Surgeons. His main interests include adult liver transplantation, hepatobiliary and pancreatic surgery, including complex surgeries using cutting-edge laparoscopic and robotic-assited (da Vinci®) surgical techniques.
Comprehensive Care for a Lifetime
One of the strengths of The Liver Institute is the team approach that makes sure each patient is taken care of in a timely manner, as well as the physicians’ philosophy of individualizing the care to the needs of each patient. Access to care is a big priority, and all the physicians at The Liver Institute excel at making themselves available to ensure patients are seen in a timely manner once they are referred to the Institute.
“We have patients who come from all over the state and even from adjacent states, so we are mindful of having all the services they might need right here in one location,” said Dr. Nazario. “All of our providers are here in the same clinic. Patients leave our office with a well-established treatment plan that was formulated, discussed, and reviewed with different specialists and other team members, including dieticians and social workers.”
Another shared philosophy among the team at The Liver Institute is the commitment to taking care of patients, not just during their immediate medical issue, but for a lifetime. “We are very focused on long-term care and on educating patients about their medical conditions,” said Dr. Nazario. “We take pride in providing patients with the knowledge and tools to understand and participate in the decision-making process that will lead to treating their illness. Accomplishing this requires time and adequate, responsible follow up. This philosophy certainly sets us apart from the rest.”
On the Leading Edge in Hepatology, Biliary and Pancreatic Disease Management, Transplantation
The active clinical research program at The Liver Institute continues to grow in both local and national recognition. Since its origins in 2003, The Liver Institute has grown and is now a major tertiary referral center for North Texas and beyond.
A nationally recognized Liver Dialysis Study—the first in North Texas—is currently underway at The Liver Institute. Additionally, The Liver Institute is the only practice in North Texas to have the new FDA-approved Fibroscan technology, which offers a noninvasive way to determine scarring or fibrosis of the liver and often eliminates the need for a biopsy. It is safe, quite accurate and saves patients time as it can be done in a few minutes during the clinic visit. “We have the expertise, gained through years of clinical and academic experience, to accurately diagnose and manage diseases of the liver, bile ducts and pancreas,” said Dr. Nazario. “We work collaboratively and are committed to consistently provide the highest quality of care to our patients.”